RIZZI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.460
EU - Europa 2.637
AS - Asia 897
SA - Sud America 9
AF - Africa 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.018
Nazione #
US - Stati Uniti d'America 4.410
IT - Italia 950
DE - Germania 486
SG - Singapore 304
CN - Cina 283
IE - Irlanda 266
SE - Svezia 205
RU - Federazione Russa 187
GB - Regno Unito 122
HK - Hong Kong 93
UA - Ucraina 93
AT - Austria 86
VN - Vietnam 59
IN - India 58
FI - Finlandia 56
CA - Canada 49
DK - Danimarca 44
BE - Belgio 36
FR - Francia 29
ID - Indonesia 21
TR - Turchia 21
JP - Giappone 18
PL - Polonia 15
NL - Olanda 13
CH - Svizzera 11
CZ - Repubblica Ceca 10
KR - Corea 10
IR - Iran 8
RO - Romania 7
BR - Brasile 6
TW - Taiwan 6
BG - Bulgaria 5
EE - Estonia 5
ES - Italia 5
EG - Egitto 4
AE - Emirati Arabi Uniti 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SC - Seychelles 3
AU - Australia 2
CO - Colombia 2
EU - Europa 2
HU - Ungheria 2
IQ - Iraq 2
MY - Malesia 2
PK - Pakistan 2
PT - Portogallo 2
TH - Thailandia 2
CL - Cile 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
Totale 8.018
Città #
Ann Arbor 1.418
Frankfurt am Main 365
Chandler 348
Wilmington 306
Fairfield 300
Woodbridge 294
Milan 270
Singapore 261
Dublin 237
Ashburn 189
Dearborn 139
Seattle 130
Houston 125
New York 110
Santa Clara 98
Cambridge 97
Hong Kong 92
Princeton 86
Jacksonville 83
Vienna 83
Nanjing 53
Rome 49
Shanghai 40
Helsinki 37
Brussels 35
Altamura 33
London 31
Lawrence 30
Pune 29
Fremont 21
Jakarta 21
Sligo 21
Guangzhou 20
San Diego 20
Monza 17
Beijing 16
Dong Ket 16
Hangzhou 16
Romola 16
Andover 15
Bari 15
Carate Brianza 15
Nanchang 15
Shenyang 15
Kunming 14
Lachine 14
Boardman 12
Hebei 11
Munich 11
Sacramento 11
Toronto 11
Falls Church 10
Melzo 10
Norwalk 10
Turin 10
Edmonton 9
Tianjin 9
Brno 8
Changsha 8
Como 8
Kiev 8
Padova 8
Tokyo 8
Genoa 7
Bergamo 6
Chiavari 6
Chicago 6
Hefei 6
Jinan 6
Ottawa 6
Pescara 6
Sesto San Giovanni 6
Zurich 6
Ankara 5
Arcore 5
Bologna 5
Brescia 5
Bresso 5
Council Bluffs 5
Jiaxing 5
Los Angeles 5
Mountain View 5
Napoli 5
Pavia 5
Storrs 5
Tallinn 5
Terni 5
Verona 5
Bolzano 4
Bonndorf 4
Bournemouth 4
Cagliari 4
Changchun 4
Cologne 4
Dallas 4
Garbagnate Milanese 4
Huizen 4
Istanbul 4
Krakow 4
Leawood 4
Totale 6.001
Nome #
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 347
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 346
Growth hormone secretagogues and the regulation of calcium signaling in muscle 316
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 311
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 300
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 270
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 268
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 251
Identificazione di nuove strategie terapeutiche per il controllo dell'obesità e della cachessia mediante utilizzo di nuovi composti peptidomimetici dotati di attività antagonista o agonista dell'ormone peptidico endogeno ghrelin 238
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 232
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 230
Effect of nutrition on neurodegenerative diseases. A systematic review 221
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 207
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 205
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 202
Parma consensus statement on metabolic disruptors 202
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 200
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 198
Neurotrophic and neuroregenerative effects of GH/IGF1 196
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 187
New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens 183
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 181
TLQP-21 modulate inflammation and fibrosis in a model of ards 180
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure 174
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 174
Characterization of synovial cytokine patterns in bucket-handle and posterior horn meniscal tears 157
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 153
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 150
Androgen therapy in neurodegenerative diseases 139
Agreement and tense as distinctive syntactic positions. Evidence from acquisition 136
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 133
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 133
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 132
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 124
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 115
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 109
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 102
The role of nutrition on Parkinson’s disease: a systematic review 102
The role of androgens in women's health and wellbeing 99
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 94
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 87
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 83
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 71
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 67
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 64
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 61
null 57
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 54
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 53
Resolvin E1 and Cytokines Environment in Skeletally Immature and Adult ACL Tears 40
Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results 36
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 20
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 20
Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction 12
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 11
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 9
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 8
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 6
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 6
Role of nutrition in degenerative disease 4
Totale 8.466
Categoria #
all - tutte 27.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.271


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020878 0 0 0 0 110 153 170 95 136 105 77 32
2020/20211.537 61 54 141 147 123 155 128 154 142 137 140 155
2021/2022889 116 96 82 84 49 58 41 31 25 90 70 147
2022/20231.542 160 359 181 145 85 232 27 105 101 29 54 64
2023/20241.151 34 67 83 82 124 246 193 67 70 59 26 100
2024/2025951 152 222 203 187 187 0 0 0 0 0 0 0
Totale 8.466